Finnish-Kenyan AIDS drug aims for global market

Business November 10, 2011

A Kenya-based pharmaceutical company in Finnfund’s investment portfolio has gained WHO approval for an HIV drug which now opens access to the giant UN and Global Fund market.

For subscribers, please log in. To become a subscriber or to read one free article, click below.